From innovation to impact: understand leading and emerging obesity therapeutics that are transforming lives and reshaping global wellness
Call for Speakers - Limited Speaking Opportunities
Research is underway for Informa's inaugural Obesity Science & Innovation event, held September 16-17, 2025 as part of Biotech Week Boston. Sign up for email updates below and contact Kaitlin Dailey at kaitlin.dailey@informa.com for speaking enquiries.
Dive into the forefront of obesity drug development
Designed for researchers from biotech and pharma, the event spotlights cutting-edge clinical advancements in GLP-1 agonism, as well as emerging next-gen approaches and modalities. Connect with peers, explore emerging science, and collaborate on developing safe, effective and durable treatments for obesity and its related comorbidities.
GLP-1 CLINICAL HIGHLIGHTS
Exploring updates from leading GLP-1, dual- and tri-agonist clinical trials, across peptide and small molecule drug modalities.
BIOLOGY & TRANSLATION
Diving into the complex biology of obesity, including the shaping of translational strategies to accelerate clinical development of therapeutics.
MAINTENANCE INNOVATION
Highlighting approaches to enhance patient adherence and weight-loss maintenance, including development of oral formulations and combating sarcopenia.
BEYOND GLP-1: RAPID FIRE
Showcasing next generation modalities and approaches in obesity therapeutics, hear fromemerging early-stage innovators who are looking at solutions beyond GLP-1, such as inflammasome inhibitors, β2AR and cannabinoid receptor agonists
RNA-BASED THERAPEUTICS
Exploring RNA-based therapeutics for obesity, including siRNA, non-coding RNA and editing approaches.
Forums
- MARKET ACCESS & REIMBURSEMENT
- MANUFACTURING & PACKAGING
- INVESTMENT & IP STRATEGY